Of all the major S&P sectors, health care has performed best over the past six months. As part of this recent strength, Health Care Select Sector SPDR Fund ( NYSEARCA: XLV ), the world’s largest healthcare exchange traded fund, reached an eight-month trading high on Tuesday.
XLV, with its $43.20B assets under management, touched an eight-month high during Tuesday's trading at $147.77 a share, a level not seen since April 11. The recent positive momentum has pushed XLV higher by 16.4% over the past two months.
Beyond XLV, here's a handful of other healthcare ETFs that have tracked to the topside over the past two months (listed along with their two-month performance):
iShares U.S. Medical Devices ETF ( IHI ) +17.3% , iShares Biotechnology ETF ( NASDAQ: IBB ) +16.6% , Fidelity MSCI Health Care Index ETF ( FHLC ) +15.6% , Vanguard Health Care ETF ( NYSEARCA: VHT ) +15.5% , iShares U.S. Healthcare ETF ( IYH ) +13.5% , and SPDR S&P Biotech ETF ( NYSEARCA: XBI ) +8.1% .
In broader market news, stock indices have traded predictably cautious on Wednesday with investors eyeing the FOMC decision this afternoon.
For further details see:
XLV, the world’s largest health care ETF, reached an 8-month high